Crystal structure of recombinant human growth and differentiation factor 5: Evidence for interaction of the type I and type II receptor-binding sites
- 1 April 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 329 (3), 1076-1086
- https://doi.org/10.1016/j.bbrc.2005.02.078
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Endoscopic Instrumented Posterolateral Lumbar Fusion with Healos and Recombinant Human Growth/Differentiation Factor-5Neurosurgery, 2004
- Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2Proceedings of the National Academy of Sciences, 2003
- The mutational spectrum of brachydactyly type CAmerican Journal of Medical Genetics, 2002
- Spinal fusion with recombinant human growth and differentiation factor‐5 combined with a mineralized collagen matrixThe Anatomical Record, 2001
- Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase ReceptorsMolecular Biology of the Cell, 2000
- Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's diseaseNeuroscience Letters, 1997
- Growth/Differentiation Factor-5 Induces Angiogenesisin VivoExperimental Cell Research, 1997
- A human chondrodysplasia due to a mutation in a TGF-β superfamily memberNature Genetics, 1996
- Cloning and Expression of Recombinant Human Growth/Differentiation Factor 5Biochemical and Biophysical Research Communications, 1994
- Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamilyNature, 1994